HomeALPMF • OTCMKTS
add
Astellas Pharma Inc
Previous close
$9.52
Year range
$9.13 - $17.00
Market cap
2.82T JPY
Avg Volume
1.60K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 414.60B | 17.04% |
Operating expense | 374.47B | 56.01% |
Net income | -33.28B | 27.85% |
Net profit margin | -8.03 | 38.33% |
Earnings per share | — | — |
EBITDA | 15.55B | -79.26% |
Effective tax rate | 31.61% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 335.69B | -15.36% |
Total assets | 3.57T | 45.31% |
Total liabilities | 1.97T | 108.06% |
Total equity | 1.60T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | -2.38% | — |
Return on capital | -3.38% | — |
Cash Flow
Net change in cash
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -33.28B | 27.85% |
Cash from operations | 71.98B | -37.73% |
Cash from investing | -22.16B | 2.47% |
Cash from financing | 30.93B | 129.60% |
Net change in cash | 81.71B | 1,742.06% |
Free cash flow | 9.41B | 126.63% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. On February 5, 2020, the company announced management changes effective from April 1, 2020.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,484